Amendment to License Agreement Sample Contracts

AMENDMENT
Amendment to License Agreement • August 26th, 2024

This amendment (“Amendment”) is effective as of the date of signature of the last party to sign as indicated below (“Amendment Effective Date”), by and between Tyler Technologies, Inc. with offices at 5101 Tennyson Parkway, Plano, Texas 75024 (“Tyler”) and Collin County, TX (“Client”).

Sample 1
AutoNDA by SimpleDocs
INDICATES CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT THAT HAVE BEEN OMITTED PURSUANT TO ITEM 601(B) OF REGULATION S-K BECAUSE THE IDENTIFIED CONFIDENTIAL PORTIONS (I) ARE NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
Amendment to License Agreement • February 12th, 2021 • MSCI Inc. • Services-business services, nec • New York

THIS AMENDMENT (this “Amendment”) dated as of December 1, 2020 (the “Amendment Effective Date”) is made to the Previous Amendment (as defined below) by and between MSCI Inc. (formerly known as Morgan Stanley Capital International Inc.) (“MSCI”) and BlackRock Fund Advisors (“Licensee”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Previous Amendment or the Agreement (as defined below), as the case may be.

Sample 1
RE: AMENDMENT: WGN Superstation
Amendment to License Agreement • September 10th, 2021
Sample 1
Amendment 151 to the Amended and Restated License Agreement for the Use and Marketing of Programming Materials dated May 31, 1996 (the "1996 Agreement") between International Business Machines Corporation and Dassault Systemes, S.A.
Amendment to License Agreement • June 29th, 2006 • Dassault Systemes Sa • Services-prepackaged software

This Amendment ("Amendment") is entered into by and between International Business Machines Corporation ("IBM"), incorporated under the laws of the State of New York and Dassault Systemes, S.A. ("OWNER"), a French société anonyme.

Sample 1
CONFIDENTIAL TREATMENT REQUESTED. *********** INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.
Amendment to License Agreement • February 22nd, 2019 • MSCI Inc. • Services-business services, nec • New York

THIS AMENDMENT (this “Amendment”) dated as of September 10, 2018 (the “Amendment Effective Date”) is made to the Previous Amendment, the Previous Conversion Amendment and the Previous Name Change Amendment (each as defined below) by and between MSCI Inc. (formerly known as Morgan Stanley Capital International Inc.) (“MSCI”) and BlackRock Fund Advisors, a California corporation (as successor to Barclays Global Investors, N.A.) (“Licensee”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Previous Amendment, the Previous Name Change Amendment, the Previous Conversion Amendment or the Agreement (as defined below), as the case may be.

Sample 1
Amendment 157 to the Amended and Restated License Agreement for the Use and Marketing of Programming Materials dated May 31, 1996 as amended (the "1996 Agreement") between International Business Machines Corporation and Dassault Systemes
Amendment to License Agreement • May 29th, 2007 • Dassault Systemes Sa • Services-prepackaged software

This Amendment ("Amendment") is entered into by and between International Business Machines Corporation ("IBM"), incorporated under the laws of the State of New York and Dassault Systemes, ("DS"), a French société anonyme, each a "party" and collectively the "parties".

Sample 1
NATIONAL INSTITUTES OF HEALTH
Amendment to License Agreement • September 13th, 2021

This is the amendment (“ Amendment”) of the agreement by and between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”), and having an effective date of and having NIH Reference Number L-XXX-200X/X (“Agreement”). This Amendment, having NIH Reference Number L-XXX-200X/X, is made between the NIH through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A., and

Sample 1
National Institutes of Health
Amendment to License Agreement • June 5th, 2012

This is the ____ amendment (“_____ Amendment”) of the agreement by and between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”), and ____ having an effective date of ____ and having NIH Reference Number L-XXX-200X/X (“Agreement”). This ___ Amendment, having NIH Reference Number L‑XXX‑200X/X, is made between the NIH through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A., and ______________, having an office at ________________________________________________ the (“Licensee”). This ___ Amendment includes, in addition to the amendments made below, 1) a Signature Page, 2) Attachment 1 (Shipping Information) and 3) Attachment 2 (Royalty Payment Information).

Sample 1
INDICATES CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT THAT HAVE BEEN OMITTED PURSUANT TO ITEM 601(B) OF REGULATION S-K BECAUSE THE IDENTIFIED CONFIDENTIAL PORTIONS (I) ARE NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
Amendment to License Agreement • February 12th, 2021 • MSCI Inc. • Services-business services, nec • New York

THIS AMENDMENT (this “Amendment”) dated as of August 19, 2020 (the “Amendment Effective Date”) is made to the Previous Amendment (as defined below) by and between MSCI Inc. (formerly known as Morgan Stanley Capital International Inc.) (“MSCI”) and BlackRock Fund Advisors (“Licensee”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Previous Amendment or the Agreement (as defined below), as the case may be.

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!